NASHVILLE, Tenn., Nov. 12 /PRNewswire/ -- Cumberland Pharmaceuticals (http://www.cumberlandpharma.com/) is pleased to announce the promotion of four senior executives. Together, Jean W. Marstiller, J. William Hix, James L. Herman and Amy Dix Rock bring more than 70 years of pharmaceutical management experience to their new positions.
“We are thrilled to recognize the contributions of these outstanding professionals,” said A.J. Kazimi, Cumberland’s Chief Executive Officer. “Each of these individuals has been instrumental in our company’s continued growth and success. Their broad experience and forward-thinking leadership will continue to be critical in our efforts to develop and acquire quality pharmaceutical products that address unmet medical needs.”
Jean W. Marstiller, who joined Cumberland Pharmaceuticals in 1999 as Vice President of Administrative Services, has been promoted to Senior Vice President and Corporate Secretary. In this position, she oversees administrative operations, human resources, site services and information systems. Ms. Marstiller has 17 years of biopharmaceutical industry experience and formerly served as Director of Administrative Operations at Therapeutic Antibodies Inc. She holds an engineering degree from Vanderbilt University and attended the Vanderbilt Owen Graduate School of Management.
As Vice President of Sales and Marketing, J. William Hix oversees the company’s sales efforts, marketing campaigns and promotional programs. Since joining Cumberland as Director of Hospital Sales in 2004, he has managed the national hospital sales force, promoted the company’s acute care product line, and was instrumental in the design and implementation of a gastroenterology product field sales force. Mr. Hix brings significant industry experience to the company, having spent 30 years at Novartis/CIBA-GEIGY Pharmaceutical Corporation. He holds a bachelor’s degree from the University of Memphis and an MBA from Our Lady of the Lake University in San Antonio.
As Senior Director of National Accounts and Corporate Compliance Officer, James L. Herman is responsible for all national accounts sales, including wholesalers, retail chains, managed care groups and federal government accounts. He also manages the company’s compliance program. Mr. Herman joined the company as Director of National Account Sales in 2003. Prior to that, he worked at Solvay Pharmaceuticals and Schwarz Pharma. He earned a bachelor’s degree from Indiana University and an MBA from Cardinal Stritch University.
Amy Dix Rock, Ph.D. has been promoted to Senior Manager of Regulatory Affairs. Joining the Company in 2001, she previously served as Senior Scientist. Dr. Rock manages all interactions between Cumberland Pharmaceuticals and the Food and Drug Administration, oversees the preparation of regulatory submissions, and manages ongoing clinical trials. She earned a bachelor’s degree from Washington University, a Ph.D. in immunology from the University of Kentucky, and an MBA from the Vanderbilt Owen Graduate School of Management.
About Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. (http://www.cumberlandpharma.com/) is a Tennessee-based specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Cumberland’s primary target markets include hospital acute care and gastroenterology. Cumberland markets Acetadote(R) for the treatment of acetaminophen poisoning and Kristalose(R), a prescription strength laxative. The Company is also developing Amelior(R) which is in Phase III studies for the treatment of both pain and fever. Cumberland is dedicated to providing innovative products which improve quality of care for patients.
CONTACT: Rebecca Kirkham, Lovell Communications Inc., +1-615-297-7766,
rebecca@lovell.com
Web site: http://www.cumberlandpharma.com/
